Research ArticleMolecular Imaging
Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW
Matthijs D. Linssen, Eva J. ter Weele, Derk P. Allersma, Marjolijn N. Lub-de Hooge, Gooitzen M. van Dam, Annelies Jorritsma-Smit and Wouter B. Nagengast
Journal of Nuclear Medicine March 2019, 60 (3) 418-423; DOI: https://doi.org/10.2967/jnumed.118.216556
Matthijs D. Linssen
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Eva J. ter Weele
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Derk P. Allersma
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Marjolijn N. Lub-de Hooge
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
3Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; and
Gooitzen M. van Dam
3Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; and
4Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Annelies Jorritsma-Smit
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Wouter B. Nagengast
2Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 3
March 1, 2019
Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW
Matthijs D. Linssen, Eva J. ter Weele, Derk P. Allersma, Marjolijn N. Lub-de Hooge, Gooitzen M. van Dam, Annelies Jorritsma-Smit, Wouter B. Nagengast
Journal of Nuclear Medicine Mar 2019, 60 (3) 418-423; DOI: 10.2967/jnumed.118.216556
Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW
Matthijs D. Linssen, Eva J. ter Weele, Derk P. Allersma, Marjolijn N. Lub-de Hooge, Gooitzen M. van Dam, Annelies Jorritsma-Smit, Wouter B. Nagengast
Journal of Nuclear Medicine Mar 2019, 60 (3) 418-423; DOI: 10.2967/jnumed.118.216556